99mTc-Labeled Bevacizumab via HYNIC for Imaging of Melanoma. Journal of Analytical Oncology, [S. l.], v. 3, n. 1, p.  53–64, 2014. DOI: 10.6000/1927-7229.2014.03.01.9. Disponível em: https://www.neoplasiaresearch.com/index.php/jao/article/view/214. Acesso em: 6 nov. 2025.